Dysregulation of LRP1-dependent signaling events contributes to the development of pathophysiologic processes such as Alzheimer’s disease, atherosclerosis, inflammation, and coagulation. This evidence concerns the gene LRP1 and early-onset autosomal dominant Alzheimer disease.